Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)

SHA:688488 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 20, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	7,473	6,871	3,307	5,264	4,427	6,539
Market Cap Growth	89.74%	107.76%	-37.17%	18.91%	-32.31%	-37.22%
Enterprise Value	7,689	7,039	3,402	5,147	4,084	5,910
Last Close Price	17.76	16.33	7.86	12.51	10.54	15.57
PS Ratio	10.39	9.56	7.92	12.80	18.13	25.57
PB Ratio	6.96	6.40	3.10	4.68	3.69	4.99
P/TBV Ratio	11.71	10.76	5.22	5.28	4.14	5.60
P/OCF Ratio	423.85	389.72	-	-	-	-
EV/Sales Ratio	10.69	9.79	8.14	12.51	16.72	23.11
EV/EBITDA Ratio	85.56	80.80	-	-	-	-
EV/EBIT Ratio	221.19	202.47	-	-	-	-
Debt / Equity Ratio	0.52	0.52	0.46	0.37	0.17	0.00
Debt / EBITDA Ratio	6.22	6.22	-	-	-	-
Net Debt / Equity Ratio	0.10	0.10	0.04	-0.03	-0.23	-0.46
Net Debt / EBITDA Ratio	1.24	1.24	-0.49	0.45	2.01	17.11
Net Debt / FCF Ratio	-3.56	-3.56	-0.57	0.12	1.19	5.60
Asset Turnover	0.38	0.38	0.23	0.24	0.16	0.18
Inventory Turnover	1.00	1.00	1.02	1.44	1.27	1.79
Quick Ratio	0.92	0.92	0.93	1.32	1.87	7.52
Current Ratio	1.32	1.32	1.38	1.78	2.42	8.94
Return on Equity (ROE)	0.76%	0.76%	-12.66%	-6.54%	-9.89%	-2.25%
Return on Assets (ROA)	1.15%	1.15%	-4.91%	-3.90%	-6.94%	-2.70%
Return on Invested Capital (ROIC)	0.98%	0.99%	-12.86%	-10.51%	-21.05%	-9.64%
Return on Capital Employed (ROCE)	2.90%	2.90%	-11.60%	-8.40%	-13.00%	-4.60%
Earnings Yield	-0.26%	-0.28%	-4.27%	-1.44%	-2.80%	-0.46%
FCF Yield	-0.41%	-0.44%	-2.48%	-4.51%	-5.26%	-1.64%
Buyback Yield / Dilution	-1.36%	-1.36%	1.73%	-2.17%	3.44%	-7.71%
Total Shareholder Return	-1.36%	-1.36%	1.73%	-2.17%	3.44%	-7.71%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.